We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-6.83%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$116M
AUM Growth
-$26.7M
(-19%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-9.44%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
117
New
6
Increased
16
Reduced
64
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
|
+$1.97M |
| 2 |
Exagen
XGN
|
+$1.41M |
| 3 |
BioLife Solutions
BLFS
|
+$1.1M |
| 4 |
AVGR
Avinger, Inc. Common Stock
AVGR
|
+$1.08M |
| 5 |
Castle Biosciences
CSTL
|
+$619K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$2.1M |
| 2 |
Digital Turbine
APPS
|
+$1.92M |
| 3 |
CryoPort
CYRX
|
+$1.22M |
| 4 |
Expeditors International
EXPD
|
+$797K |
| 5 |
Veracyte
VCYT
|
+$565K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 62.15% |
| 2 | Technology | 13.69% |
| 3 | Communication Services | 6.62% |
| 4 | Industrials | 5.98% |
| 5 | Consumer Staples | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Airgain
AIRG
$73.4M
| $773K | 0.67% |
65,800
-22,000
| -25% | -$274K |
|
52
Inuvo
INUV
$15.1M
| $747K | 0.64% |
276,483
+188,500
| +214% | +$526K |
|
53
H.B. Fuller
FUL
$2.97B
| $723K | 0.62% |
15,525
-375
| -2% | -$17.1K |
|
54
Microvision
MVIS
$6.21M
| $675K | 0.58% |
1,126,500
| – | – |
|
|
PDCO
55
DELISTED
Patterson Companies, Inc.
PDCO
| $668K | 0.58% |
37,475
-500
| -1% | -$9.34K |
|
|
AVGR
56
DELISTED
Avinger, Inc. Common Stock
AVGR
| $660K | 0.57% |
2,649
+2,077
| +363% | +$1.08M |
|
57
US Bancorp
USB
$98.2B
| $653K | 0.56% |
11,800
-1,462
| -11% | -$79K |
|
58
General Mills
GIS
$19.1B
| $646K | 0.56% |
11,725
+200
| +2% | +$10.8K |
|
59
Donaldson
DCI
$10.9B
| $633K | 0.55% |
12,150
-2,540
| -17% | -$126K |
|
60
3M
MMM
$90.9B
| $622K | 0.54% |
4,522
| – | – |
|
|
BEAT
61
DELISTED
BioTelemetry, Inc.
BEAT
| $611K | 0.53% |
15,000
| – | – |
|
|
STRM
62
DELISTED
Streamline Health Solutions
STRM
| $592K | 0.51% |
36,406
-763
| -2% | -$15.8K |
|
63
Advanced Micro Devices
AMD
$776B
| $575K | 0.5% |
19,850
-200
| -1% | -$6.27K |
|
64
Ooma
OOMA
$598M
| $562K | 0.48% |
54,050
-1,750
| -3% | -$20.5K |
|
65
Baxter International
BAX
$13.5B
| $560K | 0.48% |
6,400
| – | – |
|
66
Materion
MTRN
$4.39B
| $540K | 0.47% |
8,800
| – | – |
|
67
Deluxe
DLX
$1.18B
| $538K | 0.46% |
10,950
| – | – |
|
|
TBCH
68
Turtle Beach Corp
TBCH
$243M
| $523K | 0.45% |
44,781
-11,125
| -20% | -$110K |
|
|
69
Castle Biosciences
CSTL
$855M
| $505K | 0.44% |
+27,920
| New | +$619K |
|
70
ePlus
PLUS
$2.42B
| $457K | 0.39% |
12,000
-6,000
| -33% | -$231K |
|
71
QuickLogic
QUIK
$232M
| $457K | 0.39% |
92,857
| – | – |
|
72
Medtronic
MDT
$109B
| $456K | 0.39% |
4,200
| – | – |
|
73
Alphatec Holdings
ATEC
$1.46B
| $432K | 0.37% |
+86,000
| New | +$447K |
|
|
TTSH
74
DELISTED
Tile Shop Holdings
TTSH
| $393K | 0.34% |
123,266
-101,334
| -45% | -$310K |
|
|
PRFT
75
DELISTED
Perficient Inc
PRFT
| $378K | 0.33% |
9,800
-8,700
| -47% | -$315K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Perkins Capital Management held 117 positions worth $116M, down 19% from $143M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Perkins Capital Management withdrew a net $11M in Q3 2019, closing 5 positions and reducing 64 holdings. Its most notable exit was Expeditors International, an estimated $797K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Perkins Capital Management opened a new position in Exagen worth $1.35M.
- Perkins Capital Management's largest Q3 2019 buy was Exagen: 87,450 shares worth $1.35M.
- Perkins Capital Management added most to HTG Molecular Diagnostics, Inc. Common Stock in Q3 2019, an estimated $1.97M increase.
- Perkins Capital Management's biggest Q3 2019 reduction was Magnite, cutting an estimated $2.1M.
- Perkins Capital Management fully exited Expeditors International in Q3 2019, selling an estimated $797K.
- Perkins Capital Management's ten largest holdings make up 32% of its $116M portfolio in Q3 2019.
- Perkins Capital Management opened 6 new positions and closed 5 in Q3 2019.
- Perkins Capital Management's portfolio value fell 19% quarter-over-quarter to $116M.
Based on Perkins Capital Management's 13F filing for Q3 2019, filed 23 Oct 2019.